Clinical trial · Interventional
Pharmacist-Led Education to Improve Neutropenic Precautions in Cancer Patients
The Impact of Neutropenic Precaution Education on Knowledge, Adherence, and Infection Rates in Patients With Cancer: A Pharmacist-Led Intervention
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical trial is to test whether pharmacist-led education can improve knowledge and adherence to neutropenic precautions and reduce infection rates in adult cancer patients receiving high-risk chemotherapy. The main questions it aims to answer are: * Does pharmacist-led education improve patient knowledge of neutropenic fever prevention? * Does it increase adherence to precautionary behaviors? * Does it reduce the incidence of febrile neutropenia? Researchers will compare two groups: one receiving standard care and the other receiving additional education by a clinical pharmacist, to assess the impact on patient behavior and infection outcomes. Participants will: * Receive either standard care or a structured educational intervention that includes written materials, a counseling session, and an instructional video on neutropenic precautions. * Complete knowledge and adherence surveys before and after the intervention. * Be followed for 2-6 months to monitor adherence, infection rates, and treatment outcomes.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Febrile Neutropenia | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Pharmacist-Led Neutropenic Education Package | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention Group
- description
- Participants randomized to this arm will receive a structured pharmacist-led educational intervention aimed at improving their knowledge and adherence to neutropenic precautions. The intervention includes: * Printed Arabic-translated educational materials based on CDC guidance regarding neutropenic fever precautions. * A one-on-one counseling session delivered by a clinical pharmacist, covering topics such as neutropenia definition, risk factors, hygiene and dietary precautions, early signs of infection, and the importance of prompt medical attention. * A URL to access an educational video that reinforces the same information. * Contact information for support and follow-up. This intervention is delivered before the next chemotherapy session and is reinforced with follow-up at 2 months. Participants' knowledge and adherence will be measured pre-intervention, post-intervention (same session), and at 2 months. They will be followed for 6 months for infection incidence and outcomes.
- interventionNames
- Other: Pharmacist-Led Neutropenic Education Package
- type
- NO_INTERVENTION
- label
- Control Group
- description
- Participants in this arm will receive the routine standard care provided in the oncology clinic without the additional structured pharmacist led education. This typically includes general verbal instructions about chemotherapy but no dedicated educational session or materials specific to neutropenic precautions. Knowledge and adherence assessments will be conducted at the same time points as the intervention group to compare outcomes. FN incidence and clinical outcomes will be followed over 6 months.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: -You may be able to join this study if all of the following apply to you: * You are 18 years or older. * You have been diagnosed with any type of cancer (such as breast, colon, lymphoma, etc.). * You are currently receiving chemotherapy that has a high risk of lowering your white blood cell count. * You are receiving treatment in outpatient (infusion centers) or inpatient settings (oncology wards). Exclusion Criteria: * You cannot join this study if any of the following apply to you: * You currently have an active infection (such as fever or diagnosed illness). * You are unable to speak Arabic or English, and do not have a caregiver who can help with the study. * You have a major psychiatric condition that makes it difficult to understand or participate in the educational activities.
References
Publications (0)
Data not yet available